A61K 38/443
Acting on ch-oh groups as donors
Official title: {acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)}
A61K38/443 (Acting on ch-oh groups as donors) appears on 143 US grants and 285 published applications in this corpus.
Search patents in A61K- Granted patents
- 143
- Published applications
- 285
- Assignees
- 164
- Inventors
- 555
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 2 |
| 2003 | 0 | 1 |
| 2004 | 2 | 3 |
| 2005 | 0 | 4 |
| 2006 | 0 | 5 |
| 2007 | 3 | 8 |
| 2008 | 2 | 11 |
| 2009 | 0 | 9 |
| 2010 | 0 | 15 |
| 2011 | 3 | 14 |
| 2012 | 1 | 7 |
| 2013 | 4 | 10 |
| 2014 | 4 | 12 |
| 2015 | 2 | 9 |
| 2016 | 10 | 14 |
| 2017 | 4 | 12 |
| 2018 | 7 | 16 |
| 2019 | 6 | 13 |
| 2020 | 14 | 15 |
| 2021 | 8 | 16 |
| 2022 | 8 | 21 |
| 2023 | 7 | 18 |
| 2024 | 8 | 15 |
| 2025 | 14 | 18 |
| 2026 | 10 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Methods and materials for diagnosis and treatment of neuronal disorder26 May 2026US 12,636,264 B2Genemo Inc.
- Compositions and methods for generating physiological X chromosome inactivation26 May 2026US 12,637,697 B2Children's Medical Center Corporation
- Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions14 Apr 2026US 12,599,628 B2Purina Animal Nutrition LLC
- Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies31 Mar 2026US 12,589,136 B2The Regents of the University of Michigan
- Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers8 Oct 2026US 2026/0306589 A1Goa Therapeutics Corporation
- Combination therapies of prednisone and uricase molecules and uses thereof24 Sep 2026US 2026/0284151 A1Horizon Therapeutics USA, Inc.
- Peroxidase compositions containing improved enhancing agents17 Sep 2026US 2026/0273028 A1Flen Health Pharma NV
- Reactive and sorbent materials20 Aug 2026US 2026/0240896 A1Guild Associates, Inc.
- Enzyme composition for treating dental plaque and plaque bacterial biofilms, and for the natural whitening of tooth enamel30 Jul 2026US 2026/0216042 A1
Most cited
By later US patents
- Polypeptide formulations and methods for making, using and characterizing them97US 7,241,586 B2Medtronic MiniMed, Inc. · 2007
- Encapsulation of labile biological material91US 4,324,683 ADamon Corporation · 1982
- Temperature sensitive gel for sustained delivery of protein drugs54US 5,861,174 AUniversity Technology Corporation · 1999
- Immobilization of active protein by cross-linking to inactive protein50US 4,464,468 AAgence Nationale de Valorisation de la Recherche (ANVAR) · 1984
- Temperature sensitive gel for sustained delivery of protein drugs49US 6,482,435 B1University Technology Corporation · 2002